Latest News

Lupin buys US-based GAVIS for $880 mn

India’s third-largest pharmaceutical company Lupin announced the acquisition of New Jersey-based GAVIS Pharma and Novel Labs for $880 million.

PF to gain from equity investment

Although many labour unions have opposed the move for years, the government has implemented the new investment pattern

Market Data
Market Data